NCT04413968 (COVIDOCRECHE) is a NA clinical trial of Rapid detection test in Coronavirus, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT04413968?

NCT04413968 is sponsored by Assistance Publique - Hôpitaux de Paris.

What drugs are being tested in NCT04413968?

Interventions in NCT04413968: Rapid detection test, Nasopharyngeal swab, Stool collection.

What condition does NCT04413968 study?

NCT04413968 studies Coronavirus, Coronavirus Infection, Covid19, Sars-CoV2.

Is NCT04413968 still recruiting?

NCT04413968 is currently completed. Last updated 26 October 2020.

Last reviewed 2020-10-26 · How we verify

NCT04413968: COVIDOCRECHE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

COVID-19 Infection and Transmission in Exposed, Confined and Community-based Infants

Completed NA Last updated 26 October 2020

What this trial tests

NA trial testing Rapid detection test in Coronavirus in 600 participants. Completed in 2 October 2020.

Timeline

2 June 2020

Primary endpoint
2 July 2020

2 October 2020

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	600
Start date	2 June 2020
Primary completion	2 July 2020
Estimated completion	2 October 2020
Sites	11 locations across France

Drugs / interventions tested

Rapid detection test
Nasopharyngeal swab — full drug profile →
Stool collection — full drug profile →

Conditions studied

Coronavirus — all drugs for Coronavirus →
Coronavirus Infection — all drugs for Coronavirus Infection →
Covid19 — all drugs for Covid19 →
Sars-CoV2 — all drugs for Sars-CoV2 →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

1 Month and older, any sex, with Coronavirus or Coronavirus Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

According to epidemiological models, the seroprevalence of SARS-CoV-2 infection in Île-de-France as of 11 May was between 10 and 15%. Preliminary data on the number of professionals evicted from nurseries on suspicion of COVID-19 (on clinical grounds) seem to be of the same order of magnitude, but need to be confirmed by a biological technique. Children would be susceptible to infection but often asymptomatic.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study.
Lachassinne E, de Pontual L, Caseris M, Lorrot M, et al · · 2021 · cited 48× · PMID 33571450 · DOI 10.1016/s2352-4642(21)00024-9

Verify or expand the search:

Other recruiting trials for Coronavirus

Currently open trials in the same condition.

NCT04772170 — Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies · recruiting
NCT05868239 — Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study · NA · recruiting
NCT04359836 — A Study to Explore the Role of Gut Flora in COVID-19 Infection · recruiting
NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
NCT04568148 — COVID-19 Biorepository · active not recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04413968 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 26 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04413968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing